Thu26

04:00 PM

day:
Thursday
date:
09/26/2019
time:
4:00 PM - 5:00 PM
event:
"Anti-Obesity Drug Development: The Potential and the Challenge" by Chien Li
location:
Pinn 1-17
type:
Seminar
department:
Pharmacology
audience:
Faculty Students
details:
Hosted by Michael Scott, Chien Li, PhD is a Principal Research Scientist, Novo Nordisk Research Center, Oregon Health and Science University, Seattle, WA

Novo Nordisk’s research center in Seattle, Washington, is theepicenter of the company’s R&D activities in the US. Teams arepart of a global organization, partnering with colleagues acrossvarious international research centers. The team in Seattle is focusedon early discovery projects within the diabetes and obesity areas.Scientists apply cutting edge technologies to bring molecules tomarket. Right now, that means identifying protein and stem-cell basedtherapies for obesity, diabetes, and other chronic diseases, as wellas research on the next generation of medical devices.
URL:
http://www.novonordisk-us.com/whoweare/about-novo-nordisk/novo-nordisk-in-the-US/seattle-wa.html
isCME:
No
speakers:
Chien Li, PhD, Principal Research Scientist, Novo Nordisk Research Center, Oregon Health and Science University, Seattle, WA
registration:
No registration is necessary
contact:
Antoinette Reid Pharmacology 924-1919 adw2n@virginia.edu
Attachments:
SeminarNotice-Chien Li.pdf

Sort Events by Date

  September 2019
S M T W T F S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Sort by Department

+ Click to show departments

Search Events